Sub module 1 Introduction to HIV care and ART recording and reporting system.

Slides:

Advertisements

Similar presentations

Antiretroviral Therapy Standard Core Indicators. Emergency Plan for AIDS Relief 2 million people reached with ART 7 million new infects prevented 10 million.

Advertisements

A Guide to Monitoring and Evaluating HIV/AIDS Care and Support.

Indicators for monitoring ARV treatment outcomes.

Group III: Demand Forecasting

Reporting Requirements and Indicators for Supply Chain Management of HIV Diagnostics & Medicines: Kenya and Nigeria Yasmin Chandani, Coordinator for HIV/AIDS.

An operational package for Integrated Management of HIV/AIDS prevention, treatment and care ICASA - Abuja, Nigeria 5 December 2005.

Nigeria Case Study HIVAIDS Specific Slides. ANALYZING AND INTERPRETING DATA.

1 M&E and ART programme Sri Lanka. 2 Overview of the presentation 1.NSACP service delivery points 2.Reporting units of ART programme 3.Recording and reporting.

Follow-up after training and supportive supervision The IMAI District Coordinator Course.

EMTCT Tanzania Experience 6 th Joint Biennial HIV & AIDS Sector Review Dr MD Kajoka PMTCT Coordinator.

Patient Monitoring: Chronic HIV Care and ART Sandy Gove WHO HIV Department.

Update: National AIDS Programmes FHI, Horizons, HHS-CDC & HRSA, Macro, Measure, Synergy, USAID, WHO,UNAIDS Katherine Marconi, Ph.D., MS Presenter A Guide.

Integrated Monitoring and Evaluation of HIV Programs in Malawi Dr Andreas Jahn 1,2 1 Dept. for HIV and AIDS, MOH, Malawi 2 I-TECH Malawi.

Rakai Health Sciences Program (RHSP) Uganda Population-based Research on HIV, other Infectious Diseases, Reproductive Health and Service delivery.

The District Mentorship Initiative in Tanzania Track 1.0 Annual Meeting Redempta Mbatia ICAP Tanzania August 10 th 2010.

Trends in Antiretroviral Drugs Prescribing at Public Health Facilities in Ethiopia: Compliance to Treatment Guidelines Authors: Hailu Tadeg and Negussu.

John Aberle-Grasse CDC GAP Strategies for Building National-Scale Longitudinal Patient Monitoring Systems for HIV Treatment and Care Lusaka, October 2-5,

INTRODUCTION Sometimes Data Managers need a simplified way of knowing the clinical status as well as HIV patients management in their District Hospitals.

Treatment challenges of 2 nd /3 rd line HIV/AIDS, hepatitis-C in Seychelles BY DR LOUINE MOREL.

Situation of HIV/AIDS services in Karamoja. Introduction 1M people infected with HIV. 110,000 children

Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.

Utilizing Facility Data for Program Monitoring Valerie Koscelnik Track 1 ART Program Meeting Maputo, August 12, 2010.

Evaluating ICAP-supported Prevention of Mother to Child Transmission (PMTCT) Programs in 7 countries: Rosalind Carter, PhD Epidemiologist, PMTCT, Pediatrics.

Prevention of Mother-to-Child Transmission of HIV in Ghana

Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.

National ART Program - NAP Utilization of NAP Monitoring data for Policy Decision “Treatment as Prevention” Sorakij Bhakeecheep, MD Director National Health.

Chronic HIV Care with ART. CHALLENGES TO SELF-MANAGEMENT AND QUALITY CHRONIC CARE The acute care paradigm -Reactive care -Patient who is in office now.

Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.

Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.

Effects of Patient Tracking Systems and Providers Incentives on Patient Appointment Keeping Rwanda Pilot Study Report Nyamusore Jose 1 *, Hinda Ruton 1,

Sub module 4 Drug Dispensing and Stock Management.

Attrition in HIV Care Attrition in HIV Care: Key Operational Challenge in implementing HIV Care and Treatment in Tanzania G R Somi _________ Ministry of.

Integrating Paediatric HIV/AIDS services into exisitng adult ART services.

Monitoring and Evaluation Module 12 – March 2010.

Adolescent HIV Care and Treatment Module 14: Monitoring, Evaluation, and Quality Improvement 1.

Mpumalanga Department of Health report on Comprehensive HIV and AIDS Grant 1.

IMAI Sequence of Care Task shifting, division of labor, and the role of non-clinicians on the care team.

2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.

Ministry of Health, Mozambique

Washington D.C., USA, July 2012www.aids2012.org Lessons from the Rapid Response of Namibia’s Supply Chain When Antiretroviral Treatment Guidelines.

Orientation on HIV care and ART Recording and Reporting System.

Challenges in monitoring ARV therapy A clinical and public health view of the issues involved Charlie Gilks SRM team, HIV department.

Option B+ Weekly SMS reporting; data Use to improve service delivery Zikulah Namukwaya, MD, MPH MU-JHU Care /Mulago Hospital AIDS 2014 – Stepping Up The.

Antiretroviral Treatment Monitoring: A Canadian Case Example Antiretroviral Treatment Monitoring: A Canadian Case Example Robert Hogg, PhD BC Centre for.

Progress to date and Plans for Year 5 Overcoming HIV/AIDS epidemic in Ukraine Programme supported by the Global Fund 11 th Stakeholders’ meeting 22 nd.

Implementing the revised TB/HIV indicators and data harmonisation at country level Christian Gunneberg MO WHO Planning workshop to accelerate the implementation.

Promoting Rational Use of ARVs in HIV/AIDS Clinics in Tanzania Presented by Salama Mwakisu -MSH.

Intervention Strategy in Improving ART Adherence In Tanzania Salama Mwakisu-MSH, Dr D Sando-NACP, Dr R. Malele-MUHAS, Bernard Rabiel- NACP, Dr G. Somi-NACP,

President’s Emergency Plan for AIDS Relief 2006 Semi-Annual Program Results (SAPR) October 1, 2005 – March 31, 2006.

Understanding Monitoring & Indicators. What is Monitoring?  A continuing function that uses systematic collection of data on specified indicators to.

Monitoring Paediatric Trends in a High Prevalence Setting within KwaZulu Natal Ravikanthi Rapiti OVC IN AFRICA 01 Nov 2010.

Sub module 3 Pre-ART and ART registers. Purpose of registers Key individual information for: Facilitating patient management by the identification of.

Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.

1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.

ICAP Quarterly Master Slide Set July-September 2007.

NFM: Modular Template Measurement Framework: Modules, Interventions and Indicators LFA M&E Training February

1 Uses of Data from the WHO HIV Drug Resistance Strategy: 1. Monitoring of HIVDR emerging in treated groups in sentinel ART clinics HIV Drug Resistance.

KENYATTA NATIONAL HOSPITAL. PROMOTING RATIONAL USE OF ANTI-RETROVIRALS (ARV) AT KENYATTA NATIONAL HOSPITAL (KNH) IN KENYA BY OGILE ELIZABETH BPharm Pg.

From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.

Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.

How differentiated care supports “Tx all” and Dr

Durban, July 20th 2016 Ruggero Giuliani MSF - Mozambique

Jeopardy Game Hosted by PHDP Jamaica MODULE 4 Treatment Literacy.

By Nour Elhouda Ata Alla Assistant Professor, Consultant Paediatrician

Dr. Kathure, Weyenga and Langat

MWENGE ESTATE CLINIC, KYENJOJO DISTRICT, UGANDA,EAST AFRICA.

Paul De Lay Director, Evaluation UNAIDS

monitoring & evaluation THD Unit, Stop TB department WHO Geneva

Monitoring of Antiretroviral therapy (ART)delivery by Regional Tuberculosis Officers (RTO) in Malawi: Rhehab Chimzizi Anthony Harries Edwin Libamba Maxwell.

Update on global progress in ART

Presentation transcript:

Sub module 1 Introduction to HIV care and ART recording and reporting system

Objectives of programme monitoring At facility level To support patient management To support drug supply management At all levels To document the progress in equitable access to care and ART To identify successes and gaps, and revise the programme accordingly

Overview (1) Patient monitoring data: Patient medical record Program monitoring data: Aggregated from individual patient records Indicators (international/national agreement) Computerized or manual system  Continuity of care

Core international indicators (1) Input National policy and guidelines 1. Existence of national policy and guidelines for ART Process Programme coverage 2. % of districts or local health administration units with at least one health facility providing ART services in line with national standards Drug supply3. % of ARV storage and delivery points experiencing stock-outs in the preceding 6 months Human ressources 4. Number of health workers trained on ART delivery in accordance with national or international standards

Core international indicators (2) OutputProgram coverage 5. % of health facilities with systems and items to provide ART services Care coverage 6. % of health facilities with ART services that also provide comprehensive care, including prevention services, for HIV+ clients OutcomePeople on Rx 7. % of people with advanced HIV infection receiving ARV combination therapy Continuation 1 st line 8. Continuation of 1 st line regimens at 6, 12 and 24 months ImpactSurvival 9. Survival at 6, 12, 24, 36 etc. months after initiation of treatment

Core indicators at facility level (1) Monthly report (transversal) 1. Cumulative number of patients enrolled in HIV care 2. Number started on ART during a reporting period 3. Cumulative number ever started on ART 4. Cumulative number medically eligible for ART but have not been started on ART  By sex, age (adult/children) 5. Cumulative number on ART 6. Cumulative number on substituted 1 st line 7. Cumulative number switched on 2 nd line 8. Proportion with >95% adherence

Core indicators at facility level (2) Cohort report (longitudinal) 9. Proportion alive and on treatment 6, 12, 24 months after initiating ART 10. Proportion of patients continuing initial 1st line regimen, substituting 1st line, switched to 2nd line at 6, 12, 24 months of ART 11. Change in CD4 after 6, 12, 24 months 12. Proportion with normal activity at 6,12, 24 months after initiating 13. Proportion who picked up their drugs 6/6, 12/12 months

Recording and reporting tools Reports Monthly report Cohort analysis report Records Patient HIV care/ART record patient booklet Pre-ART register ART register Drug dispensing register Drug stock register

Monthly and Cohort report WHY? To report and analyze indicators WHEN? Every month for the monthly report Every quarter for the cohort report WHO? Manager of the clinic Trained staff under supervision